Clinically Proven Radiopharmaceuticals for Infection Imaging: Mechanisms and Applications
Authors:
- Stanley J. GoldsmithSGStanley J. Goldsmith
- Shankar VallabhajosulaSVShankar Vallabhajosula
- 1 January 2009
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 39 (1) , 2-10
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown originEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Pneumocystis carinii InfectionArchives of Pathology & Laboratory Medicine, 2004
- OsteomyelitisThe Lancet, 2004
- Biological Mediators of Acute InflammationAACN Advanced Critical Care, 2004
- Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, l -methionine, 67 Ga-citrate, and 125 I-HSAEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor modelsNuclear Medicine and Biology, 1996
- The utility of [99mTc]HMPAO-leukocytes for imaging infectionSeminars in Nuclear Medicine, 1994
- The use of radiolabeled, nonspecific immunoglobulin in the detection of focal inflammationSeminars in Nuclear Medicine, 1994
- Scintigraphic evaluation of disease activity in rheumatoid arthritis: a comparison of technetium-99m human non-specific immunoglobulins, leucocytes and albumin nanocolloidsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1992
- The mechanism of tumor localization of gallium-67 citrate: Role of transferrin binding and effect of tumor pHInternational Journal of Nuclear Medicine and Biology, 1981